We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Mycobacterium tuberculosis and the response of its host
-
2. The pathogenesis of tuberculosis
- Dr. William R. Bishai
-
3. Immune response and rational development of vaccines and biomarkers
- Prof. Dr. Stefan H. E. Kaufmann
-
4. Molecular mechanisms of drug resistance in M. tuberculosis
- Dr. Daniela Cirillo
- The epidemiology of tuberculosis
-
5. The basic epidemiology of tuberculosis (TB)
- Dr. David Dowdy
-
6. Global epidemiology of TB
- Dr. Philippe Glaziou
-
7. Social determinants of tuberculosis
- Dr. Knut Lönnroth
- The control of tuberculosis
-
8. Treatment of tuberculosis
- Dr. Jean-Pierre Zellweger
-
9. The End TB Strategy towards TB elimination 1
- Dr. Mario Raviglione
-
10. The End TB Strategy towards TB elimination 2
- Dr. Mario Raviglione
-
11. Financing TB care and control
- Dr. Christopher Fitzpatrick
- Dr. Andrea Pantoja
-
12. Tuberculosis and COVID-19
- Prof. Giovanni Battista Migliori
-
13. Multidrug resistant tuberculosis (MDR-TB): an update
- Dr. Simon Tiberi
-
14. Impact of HIV on tuberculosis in the developing world and how to manage it
- Prof. Anthony D. Harries
-
16. TB in children
- Prof. Ben J. Marais
-
17. Community engagement in tuberculosis care
- Ms. Lana Syed
-
18. India: the epicentre of global TB control
- Dr. Madhukar Pai
-
19. Community engagement in TB care
- Dr. Haileyesus Getahun
- Research and development for new approaches in the control of tuberculosis
-
20. Development of new regimens for tuberculosis
- Dr. Zhenkun Ma
-
22. Pharmacometrics in tuberculosis
- Prof. Charles A. Peloquin
-
23. Extrapulmonary tuberculosis
- Dr. Scott Heysell
-
24. The role of surgery in tuberculosis management
- Dr. Richard Zaleskis
- Archived Lectures *These may not cover the latest advances in the field
-
25. The development of current treatments for tuberculosis
- Dr. Andrew Nunn
-
26. The pathogenesis of tuberculosis
- Dr. William R. Bishai
-
27. Basics of tuberculosis epidemiology
- Prof. Frank Cobelens
-
29. The international approach to the control of tuberculosis
- Dr. Mario Raviglione
-
30. Public-private mix for TB care and control
- Dr. Mukund Uplekar
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- The global burden of TB - 2010
- TB incidence rates - 2010
- Impact of HIV on TB in Africa
- % MDR-TB among new TB cases 1994-2009
- Absolute numbers of reported MDR-TB cases
- 13 top settings with highest % of MDR-TB
- Time trends in TB and MDR-TB
- Countries with at least one XDR-TB case
- Progress towards international targets
- Stop TB strategy and global plan
- The global TB control targets
- Achievements thus far, 2011
- Incidence, prevalence and mortality rates
- Reductions in TB cases and deaths in China
- TB cases and deaths, absolute numbers
- Notifications of MDR-TB increasing
- Case notifications by region, 1990-2010
- Global notifications
- Challenges in 2011
- Challenges in 2011 if we target "elimination"
- Funding required, global plan
- Underfunding persists
- Funding for TB control increasing
- BRICS mostly domestic funding
- HIV testing for TB patients expanding
- CPT and ART for HIV+ TB patients
- Policy on collaborative TB/HIV activities
- Treatment success 87% globally
- TB patients tested for MDR-TB remain low
- Response to M/XDR-TB in 27 HBCs
- Critical steps for prevention and control
- Policy changes are fundamental
- Increasing notifications via PPM
- Increasing case notifications is good
- Limitations of diagnostics, drugs and vaccine
- 2015 MDG target reached but TB not eliminated
- Actions needed
- Tuberculosis control and elimination
- Innovative action needed in 4 spheres
- Population attributable fraction
- Potential impact of new TB vaccines
- A step ahead in diagnosis: introducing GeneXpert
- Roll-out of Xpert MTB/RIF
- Current TB therapy and unmet needs
- Global TB drug pipeline, June 2011
- Conclusions
- Many thanks to all
Topics Covered
- Burden of tuberculosis
- HIV-associated tuberculosis and multidrug-resistant tuberculosis
- Progress towards achievement of international targets
- Challenges in 2012
- Interventions needed in four areas; intensification of core tuberculosis control and care efforts, bold health policies, increased research efforts, and alleviation of socio-economic determinants of tuberculosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Raviglione, M. (2013, February 28). The international approach to the control of tuberculosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2024, from https://doi.org/10.69645/TLAV1259.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Mario Raviglione has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.